Markets

Insider Trading

Hedge Funds

Retirement

Opinion

10 Penny Stocks with Insider Buying

In this piece, we will take a look at ten penny stocks with insider buying. For more penny stocks, head on over to 5 Penny Stocks with Insider Buying.

With the first quarter of 2023 coming to an end, the stock market continues to be in a topsy-turvy environment. 2023 was off to a strong start with major markets such as the New York Stock Exchange (NYSE) and the NASDAQ Composite posting double digit returns after taking months of beatings in 2022 due to rising inflation and interest rates. However, the glory of 2023 was put to a screeching halt by the chairman of the Federal Reserve’s Monetary Policy Committee (MPC) Mr. Jerome Powell as he took the stand in Congress as part of his semiannual monetary policy report. Chairman Powell, who has been forced to take an aggressive approach towards interest rates as part of his institution’s battle against inflation, had signaled earlier that the Fed might take the foot off the pedal and reduce the pace of its interest rate hikes to 25 basis points (o.25%) since inflation appeared to be cooling down.

However, both he and investors were surprised in February 2023 when inflation data for January saw prices increase once again and potentially signaled that the central bank’s fight against inflation still had some way to go. Mr. Powell confirmed these fears, as he testified to Congress that:

With inflation well above our longer-run goal of 2 percent and with the labor market remaining extremely tight, the FOMC has continued to tighten the stance of monetary policy, raising interest rates by 4-1/2 percentage points over the past year. We continue to anticipate that ongoing increases in the target range for the federal funds rate will be appropriate in order to attain a stance of monetary policy that is sufficiently restrictive to return inflation to 2 percent over time. In addition, we are continuing the process of significantly reducing the size of our balance sheet.

While on the surface these remarks appear to be benign, they are anything but. The ‘target range’ that Mr. Powell mentioned is the peak benchmark interest rate that his organization will hike rates up to before stopping. This is a crucial metric since it influences investor estimates about the base rate that they should expect from the stock market, and the higher it goes, the more they become wary of the stock market.

In this backdrop, investing in the market right now is a daunting task. Take for instance the shares of Tesla, Inc. (NASDAQ:TSLA). The largest electric vehicle maker in the U.S. faced a bloodbath in 2022, but is off to a strong start this year when its year to date price growth is considered. Tesla’s shares are up by 67.8% year to date. However, over the past month, the shares are down by 12%, indicating the highly volatile nature that is currently the main feature of most stocks.

One segment of the market that is relatively safer to invest in only when the entry price is considered is the penny stock segment. Penny stocks are defined as those whose share price is below $5. Penny stocks are quite controversial as well, especially since in the stock market, not money, but the information is king. If you can legally find out the right set of facts before others, and use them to make an investment, then you can profit from both a growth in share price by going long or its fall by going short. Penny stocks offer the potential for both massive returns due to their low entry points, and big losses due to wild price fluctuations that can bite out double digit percentages from the price at a moment’s notice. Not to mention, they are also often used as pump and dump scams where fraudsters buy shares in bulk, drive the price up, convince unsuspecting investors to also ‘catch in on the trend’, and once enough people have piled in, sell in bulk to reap the illicit profits.

This uncertainty around penny stocks combined with the fact that firms in the penny stock category are often not well covered by either the media or analysts leave a considerable amount of risk out in the open when investing in them. However, one area of interest that can potentially be of aid is insider transactions – where the firm’s management themselves buy the shares. These transactions are required to be reported to the SEC, and they often provide insight into a firm.

Today we’ve done just this for penny stocks, and some of these that are currently seeing insider attention are Summit Therapeutics Inc. (NASDAQ:SMMT), Flotek Industries, Inc. (NYSE:FTK), and OPKO Health, Inc. (NASDAQ:OPK).

Photo by Ruben Sukatendel on Unsplash

Our Methodology

We used a stock screener to list down all penny stocks that have had significant insider transactions reported during the ten days ending on March 8, 2023. Then, all the transactions were filtered for the purchases, added up for a final dollar amount, and ranked to make a final list out of which the top ten are selected and listed here. If you’re interested in more penny stocks, be sure to check out 15 Most Profitable Penny Stocks.

10 Penny Stocks with Insider Buying

10. Ensysce Biosciences, Inc. (NASDAQ:ENSC)

Total Value of Insider Purchases: ~$128,000

Number of Hedge Fund Investors in Q4 2022: 16

Ensysce Biosciences, Inc. (NASDAQ:ENSC) is a biotechnology company headquartered in La Jolla, California. The firm sells drugs for opioid abuse, pain, fibrosis, and other diseases.

Ensysce Biosciences, Inc. (NASDAQ:ENSC)’s director Bob Gower bought 270,000 shares of the firm for roughly $128,000 in March 2022. The firm’s shares started to trade on the stock market in 2021, and it announced in February 2023 that it has finished gathering trial data for an abuse drug and had locked the dataset. Two out of the 943 hedge funds surveyed by Insider Monkey during last year’s fourth quarter had bought the firm’s shares.

Summit Therapeutics Inc. (NASDAQ:SMMT), Flotek Industries, Inc. (NYSE:FTK), and OPKO Health, Inc. (NASDAQ:OPK) are met by Ensysce Biosciences, Inc. (NASDAQ:ENSC) as a penny stock with insider interest.

9. Gran Tierra Energy Inc. (NYSE:GTE)

Total Value of Insider Purchases: $129,000

Number of Hedge Fund Investors in Q4 2022: 16

Gran Tierra Energy Inc. (NYSE:GTE) is a Canadian oil and gas exploration firm. It is headquartered in Calgary, Canada, and has operations in Columbia and Ecuador. The firm has total proved reserves of 25 million barrels.

Gran Tierra Energy Inc. (NYSE:GTE)’s chief executive officer Mr. Guidry Gary bought 150,000 shares of the firm for $129,000 on March 3, 2023. Insider Monkey scouted 943 hedge fund portfolios for their December quarter of 2022 investments and found out that 16 had invested in the company.

Gran Tierra Energy Inc. (NYSE:GTE)’s largest investor in our database is Thomas E. Claugus’ GMT Capital which owns 22.5 million shares that are worth $22 million.

8. TETRA Technologies, Inc. (NYSE:TTI)

Total Value of Insider Purchases: ~$205,000

Number of Hedge Fund Investors in Q4 2022: 18

TETRA Technologies, Inc. (NYSE:TTI) is an American oil and gas equipment and services provider headquartered in The Woodlands, Texas. The firm provides oil companies with products and services for well drilling and completion, alongside letting them manage water on their sites.

TETRA Technologies, Inc. (NYSE:TTI) chief executive officer and chief financial officer bought 60,00 shares in March 2023 for an approximately $205,000 stake. The company is currently developing bromine resources in Arkansas. 18 of the 943 hedge funds part of Insider Monkey’s Q4 2022 survey had bought a stake in TETRA Technologies, Inc. (NYSE:TTI).

Out of these, Graham Morris’ Highland Peak Capital is TETRA Technologies, Inc. (NYSE:TTI)’s largest investor. It owns 3 million shares that are worth $10 million.

7. Asensus Surgical, Inc. (NYSE:ASXC)

Total Value of Insider Purchases: $207,577

Number of Hedge Fund Investors in Q4 2022: 3

Asensus Surgical, Inc. (NYSE:ASXC) is a medical devices company headquartered in Durham, North Carolina. The firm develops and sells robots that help surgeons during surgery. Its products include a four armed robot, instruments, hooks, and energy devices to melt tissue.

Asensus Surgical, Inc. (NYSE:ASXC)’s director Biffi Andrea bought 293,077 shares of the company that cost $207,577 on March 3, 2023. The company is quite confident about its robots’ prowess, as it believes that the Food and Drug Administration (FDA) will soon clear them for pediatric use as well.

Insider Monkey dug through 943 hedge fund holdings for their fourth quarter of 2022 investments and found out that three had also bought Asensus Surgical, Inc. (NYSE:ASXC)’s shares.

6. ObsEva SA (NASDAQ:OBSV)

Total Value of Insider Purchases: $440,000

Number of Hedge Fund Investors in Q4 2022: N/A

ObsEva SA (NASDAQ:OBSV) is a biotechnology company that is based in Geneva, Switzerland. The firm focuses on developing treatments for women who are suffering from uterus diseases resulting from fibrosis, women who are undergoing vitro fertilization, and other issues.

ObsEva SA (NASDAQ:OBSV)’s director Loumaye Ernest bought a massive four million shares of the company for $440,000 on February 28, 2023. The firm is currently downsizing its U.S. operations to save on costs and plans to operate primarily from Switzerland.

Flotek Industries, Inc. (NYSE:FTK), OPKO Health, Inc. (NASDAQ:OPK), and Summit Therapeutics Inc. (NASDAQ:SMMT) are some penny stocks with insider buying.

Click to continue reading and see 5 Penny Stocks with Insider Buying.

Suggested Articles:

Disclosure: None. 10 Penny Stocks with Insider Buying is originally published on Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

A New Dawn is Coming to U.S. Stocks

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…